CONMED Corporation (CNMD)
CONMED Corporation is a medical technology company focused on devices and equipment used in surgical procedures. Its product portfolio spans orthopedic surgery solutions, including soft tissue fixation products, resection instruments, fluid management systems, visualization systems, and related single-use products used in minimally invasive sports medicine procedures. The company also markets powered bone surgery systems under the Hall brand for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries.
In general surgery, CONMED supplies clinical insufflation systems, smoke removal devices, endomechanical products, and electrosurgical systems. It also provides endoscopic technologies for gastroenterology procedures, along with products used in dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring. The company sells primarily to hospitals, ambulatory surgery centers, and other healthcare institutions, and also distributes through medical specialty channels. CONMED was incorporated in 1970 and is headquartered in Largo, Florida.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-CNMD
|
$74.22
|
50.7% Upside
|
Bargain
|
$45.50
|
-7.6% Downside
|
Fair
|
Great
|
0.0%
|
26.1x
|
1.4x
|
1.1x
|
1.475 B
|
2.272 B
|
36.3%
|
99.0%
|
3.9
|
21.9%
|
238.0%
|